Honigman Advises Nuwellis on its $5.0 Million Underwritten Public Offering

Nuwellis, Inc. (Nasdaq: NUWE), a commercial-stage medical device company, closed a public offering of 2,580,667 shares of its Common Stock, pre-funded warrants to purchase 14,085,998 shares of Common Stock, Series A Warrants to purchase 49,999,995 shares of Common Stock and Series B Warrants to purchase 16,666,665 shares of Common Stock for gross proceeds of approximately $5.0 million. The offering closed on June 10, 2025.

The public offering price per share of Common Stock and accompanying warrants was $0.30 and the public offering price per pre-funded warrant and accompanying warrants was $0.2999.

Honigman represented Nuwellis in the offering, led by Corporate Partners Phillip D. Torrence, N. Danny Shulman and Jessica M. Herron, with support from Associate Sarah E. Meinel.